Management of cT4 Prostate Cancer
Weranja K.B. Ranasinghe, Chad A. Reichard, Tharakeswara Bathala, Brian F. Chapin
Research output: Contribution to journal › Review Article › Research › peer-review
While radiotherapy with androgen deprivation therapy is the current standard of care for the treatment of stage cT4 prostate cancer (PC), surgery may also be an appropriate option in selected patients as part of a multimodal approach. The role and the sequence with which to optimize therapy combinations in this setting are still unknown. This mini review summarizes the current evidence for management of cT4 PC.
Patient summary: This mini review examines current evidence for the treatment options for locally advanced prostate cancer. The role of surgery in these patients can be considered as part of a combination treatment strategy along with other modalities such as radiotherapy and hormone therapy.
European Urology Focus
https://doi.org/10.1016/j.euf.2019.06.012
Locally advanced prostate cancer
10.1016/j.euf.2019.06.012
Ranasinghe, W. K. B., Reichard, C. A., Bathala, T., & Chapin, B. F. (2020). Management of cT4 Prostate Cancer. European Urology Focus, 6(2), 221-226. https://doi.org/10.1016/j.euf.2019.06.012
Ranasinghe, Weranja K.B. ; Reichard, Chad A. ; Bathala, Tharakeswara et al. / Management of cT4 Prostate Cancer. In: European Urology Focus. 2020 ; Vol. 6, No. 2. pp. 221-226.
@article{23fe1b17f0884e05a2ed3c35c24bed59,
title = "Management of cT4 Prostate Cancer",
abstract = "While radiotherapy with androgen deprivation therapy is the current standard of care for the treatment of stage cT4 prostate cancer (PC), surgery may also be an appropriate option in selected patients as part of a multimodal approach. The role and the sequence with which to optimize therapy combinations in this setting are still unknown. This mini review summarizes the current evidence for management of cT4 PC.Patient summary: This mini review examines current evidence for the treatment options for locally advanced prostate cancer. The role of surgery in these patients can be considered as part of a combination treatment strategy along with other modalities such as radiotherapy and hormone therapy.",
keywords = "cT4, Locally advanced prostate cancer, Management, Prostate cancer, t4, Treatment",
author = "Ranasinghe, {Weranja K.B.} and Reichard, {Chad A.} and Tharakeswara Bathala and Chapin, {Brian F.}",
note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
doi = "10.1016/j.euf.2019.06.012",
journal = "European Urology Focus",
Ranasinghe, WKB, Reichard, CA, Bathala, T & Chapin, BF 2020, 'Management of cT4 Prostate Cancer', European Urology Focus, vol. 6, no. 2, pp. 221-226. https://doi.org/10.1016/j.euf.2019.06.012
Management of cT4 Prostate Cancer. / Ranasinghe, Weranja K.B.; Reichard, Chad A.; Bathala, Tharakeswara et al.
In: European Urology Focus, Vol. 6, No. 2, 15.03.2020, p. 221-226.
T1 - Management of cT4 Prostate Cancer
AU - Ranasinghe, Weranja K.B.
AU - Reichard, Chad A.
AU - Bathala, Tharakeswara
AU - Chapin, Brian F.
N1 - Publisher Copyright: © 2019 European Association of Urology Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
N2 - While radiotherapy with androgen deprivation therapy is the current standard of care for the treatment of stage cT4 prostate cancer (PC), surgery may also be an appropriate option in selected patients as part of a multimodal approach. The role and the sequence with which to optimize therapy combinations in this setting are still unknown. This mini review summarizes the current evidence for management of cT4 PC.Patient summary: This mini review examines current evidence for the treatment options for locally advanced prostate cancer. The role of surgery in these patients can be considered as part of a combination treatment strategy along with other modalities such as radiotherapy and hormone therapy.
AB - While radiotherapy with androgen deprivation therapy is the current standard of care for the treatment of stage cT4 prostate cancer (PC), surgery may also be an appropriate option in selected patients as part of a multimodal approach. The role and the sequence with which to optimize therapy combinations in this setting are still unknown. This mini review summarizes the current evidence for management of cT4 PC.Patient summary: This mini review examines current evidence for the treatment options for locally advanced prostate cancer. The role of surgery in these patients can be considered as part of a combination treatment strategy along with other modalities such as radiotherapy and hormone therapy.
KW - cT4
KW - Locally advanced prostate cancer
KW - Prostate cancer
KW - t4
KW - Treatment
U2 - 10.1016/j.euf.2019.06.012
DO - 10.1016/j.euf.2019.06.012
JO - European Urology Focus
JF - European Urology Focus
Ranasinghe WKB, Reichard CA, Bathala T, Chapin BF. Management of cT4 Prostate Cancer. European Urology Focus. 2020 Mar 15;6(2):221-226. https://doi.org/10.1016/j.euf.2019.06.012